Vice President, R&D and Corporate Development
Charlie Dean joined Apollo Endosurgery in 2010. Reporting directly to the CEO, he is responsible for leading the Research and Development function and the execution of strategic business initiatives including acquisitions, partnership or technology investment opportunities. In 2013 he was an integral part of the Lap-Band & Orbera acquisition from Allergan PLC, going on to lead the worldwide integration. In 2015 he served as interim general manager for Apollo’s European operations, returning to Austin HQ in 2016.
Mr. Dean came to Apollo Endosurgery from PA Consulting Group, where he supported his med-tech and pharmaceutical clients in Europe & the US through critical business inflexion points. His expertise spans new product commercialization, post M&A integration and business development.
Mr. Dean holds a Masters in Mechanical & Manufacturing Engineering from The University of Birmingham. He is a Chartered Engineer (CEng) & Certified Project Manager (PMP).